OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

AZA/  GB0009895292  /

Frankfurt
5/21/2024  2:01:31 PM Chg. +1.7500 Volume Bid5:35:08 PM Ask5:35:08 PM Market Capitalization Dividend Y. P/E Ratio
143.0500EUR +1.24% 957
Turnover: 136,432.3000		 145.5000Bid Size: 20 146.9000Ask Size: 20 225.27 bill.EUR - -
TeleTrader 8:23 AM AstraZeneca to deliver $80B total revenue by 2030
TeleTrader 5/20 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 5/14 Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-17215...
GlobeNewswire 5/8 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 5/6 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 5/6 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 5/2 Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 5/2 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 4/29 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 4/25 Europe opens mostly down after corporate earnings
TeleTrader 4/25 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 3/28 SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/28 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire 3/26 SELLAS Announces Positive Topline Data from the Phase 2a Study of SLS009 in r/r AML and Provides Ste...
TeleTrader 3/19 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 3/18 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 3/14 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 3/14 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 3/1 SELLAS Life Sciences Delivers Oral Presentation of SLS009 Phase 1 Data for Acute Myeloid Leukemia Pa...
GlobeNewswire 2/29 Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highli...
GlobeNewswire 2/28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 2/27 Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 2/26 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 2/26 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire 2/22 Gracell Biotechnologies Acquisition Completed